Cambridge Cognition Holdings PLC
F:1M7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ryanair Holdings PLC
ISEQ:RYA
|
IE |
|
B
|
Bishop Capital Corp
OTC:BPCP
|
US |
|
Knosys Ltd
ASX:KNO
|
AU |
|
Medx Health Corp
XTSX:MDX
|
CA |
|
N
|
Nordex SE
DUS:NDX1
|
DE |
|
N
|
Noble Metal Group Inc
XTSX:NMG.H
|
CA |
|
Lotus Resources Ltd
OTC:LTSRD
|
AU |
|
U
|
United Utilities Group PLC
F:UUEC
|
UK |
|
R
|
Rotshtein Realestate Ltd
TASE:ROTS
|
IL |
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| UK |
|
Cambridge Cognition Holdings PLC
LSE:COG
|
18m GBP |
Loading...
|
|
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD |
Loading...
|
|
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
27.3B USD |
Loading...
|
|
| AU |
|
Pro Medicus Ltd
ASX:PME
|
13.8B AUD |
Loading...
|
|
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY |
Loading...
|
|
| SE |
|
Sectra AB
STO:SECT B
|
46.6B SEK |
Loading...
|
|
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.3B USD |
Loading...
|
|
| US |
|
Doximity Inc
NYSE:DOCS
|
4B USD |
Loading...
|
|
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR |
Loading...
|
|
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
19.4B CNY |
Loading...
|
|
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
250.4B INR |
Loading...
|
Market Distribution
| Min | -1 510% |
| 30th Percentile | 0.4% |
| Median | 0.5% |
| 70th Percentile | 0.7% |
| Max | 7 323.1% |
Other Profitability Ratios
Cambridge Cognition Holdings PLC
Glance View
Cambridge Cognition Holdings Plc is a neuroscience digital health company, which engages in the development of digital health products to better understand, detect, and treat conditions affecting brain health. The firm develops and markets digital solutions to assess brain health for sale worldwide, principally in the United Kingdom, the United States and Europe. Its products include CANTAB Recruit, CANTAB Connect, Cognition Kit, Cognition eCOA, CANTAB Connect Research, CANTAB Mobile, CANTAB BrainHealth, CANTAB Insight and NeuroVocalix. Its services include neuroscience consultancy, study design, data analysis, study management, data management plan, reporting and interpretation and technical consultancy. Its CANTAB Connect offers digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas. Its Cognition Kit is a custom-designed digital health platform delivering wearable and smartphone applications for high frequency data collection to demonstrate treatment efficacy and increase the understanding of a disease and a patient's response to medication.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Cambridge Cognition Holdings PLC is 80.1%, which is above its 3-year median of 79.1%.
Over the last 3 years, Cambridge Cognition Holdings PLC’s Gross Margin has increased from 79.8% to 80.1%. During this period, it reached a low of 73.5% on Jun 30, 2023 and a high of 81.1% on Dec 31, 2024.
